Saturday, May 11, 2024 8:25:24 AM
https://finance.yahoo.com/news/renalytix-report-financial-results-third-110000560.html
Recent RNLX News
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 06/05/2024 08:31:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 11:15:15 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/15/2024 02:09:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 01:23:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 11:20:02 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 11:00:16 AM
- Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024 • GlobeNewswire Inc. • 05/15/2024 11:00:14 AM
- Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15 • GlobeNewswire Inc. • 05/09/2024 11:00:12 AM
- Renalytix Announces Financing with Expected Size of up to $4 Million • GlobeNewswire Inc. • 04/08/2024 11:00:23 AM
- KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD) • GlobeNewswire Inc. • 03/14/2024 11:00:45 AM
- Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024 • GlobeNewswire Inc. • 02/15/2024 12:00:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 12:00:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:31:06 PM
- Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference • GlobeNewswire Inc. • 02/09/2024 02:00:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 12:15:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 12:15:09 PM
- New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney disease • GlobeNewswire Inc. • 01/10/2024 12:00:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 09:02:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 11/17/2023 09:01:52 PM
- Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024 • GlobeNewswire Inc. • 11/14/2023 12:00:24 PM
- Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14 • GlobeNewswire Inc. • 11/07/2023 12:00:59 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/03/2023 08:04:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 12:00:11 PM
- US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix • GlobeNewswire Inc. • 10/06/2023 11:00:19 AM
- Renalytix Reports Full Year Fiscal 2023 Results • GlobeNewswire Inc. • 09/28/2023 11:00:49 AM
DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • SONGD • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM